Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: concern for immortal time bias effect

Detalles Bibliográficos
Autores principales: Riggs, Julie M., Charya, Ananth V., Eberlein, Michael H., Reed, Robert M., Saharia, Kapil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829030/
https://www.ncbi.nlm.nih.gov/pubmed/36695703
http://dx.doi.org/10.1016/j.ajt.2022.11.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829030/
https://www.ncbi.nlm.nih.gov/pubmed/36695703
http://dx.doi.org/10.1016/j.ajt.2022.11.021

Ejemplares similares